Cart
sales@molnova.com
2-((9R10S11R15S)-1214-dioxo-910-dih
CAS No. 475100-30-2
2-((9R10S11R15S)-1214-dioxo-910-dih( —— )
Catalog No. M21585 CAS No. 475100-30-2
2-((9R10S11R15S)-1214-dioxo-910-dih is a chemical compound.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 10MG | 30 | In Stock |
|
| 25MG | 46 | In Stock |
|
| 50MG | 73 | In Stock |
|
| 100MG | 109 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name2-((9R10S11R15S)-1214-dioxo-910-dih
-
NoteResearch use only, not for human use.
-
Brief Description2-((9R10S11R15S)-1214-dioxo-910-dih is a chemical compound.
-
Description2-((9R10S11R15S)-1214-dioxo-910-dih is a chemical compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number475100-30-2
-
Formula Weight389.4
-
Molecular FormulaC24H23NO4??
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCCC(N1C(=O)C2C(C3c4ccccc4C2c2ccccc32)C1=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Spectinomycin sulfat...
Spectinomycin sulfate hydrate is a broad-spectrum antibiotic and inhibits the growth of a variety of gram-positive and gram-negative organisms. Spectinomycin sulfate hydrate acts by selectively targeting to the bacterial ribosome and interrupting protein synthesis. Spectinomycin sulfate hydrate is also a noncompetitive inhibitor of td intron RNA with an Ki value of 7.2 mM-.
-
3-Angeloyloxy-4-sene...
3'-Angeloyloxy-4'-senecioyloxy-2',3'-dihydrooroselol is a natural product for research related to life sciences.
-
Magrolimab
Magrolimab (Hu5F9-G4) is a humanized anti-CD47 IgG4 monoclonal antibody that exhibits antitumor activity by blocking CD47 and binding primarily to the N-terminal pyroglutamate of CD47. It can be used in combination with other compounds for the treatment of recurrent myeloma.
